The counter opened at Rs 346.85 and touched an intraday high and low of Rs 346.85 and Rs 340.95, respectively, in the session so far. The stock of Biocon Ltd. quoted a 52-week high of Rs 487.7 and a 52-week low of Rs 327.75.
As per BSE, the total market cap of the Biocon Ltd. stood at Rs 41060.52 crore at the time of writing this report.
Key Financials
The company reported consolidated sales of Rs 1807.8 crore for the quarter ended 30-Jun-2021, down 11.56 per cent from previous quarter’s Rs 2044.1 crore and down 7.0 per cent from the year-ago quarter’s Rs 1689.6 crore.
The net profit for latest quarter stood at Rs 84.4 crore, down 43.51 per cent from the corresponding quarter last year.
Shareholding pattern
As of 30-Sep-2021, domestic institutional investors held 2.58 per cent stake in the company, while foreign institutional investors held 15.74 per cent and the promoters 39.73 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 60.79 and a price-to-book ratio of 6.51. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Biocon Ltd. belongs to the Pharma – Indian industry.
